Study of genes and proteins in children with nephrotic syndrome
Part of Blood & lymphatic, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at children newly diagnosed with nephrotic syndrome to understand how genes and proteins in the blood might predict the disease's course and response to treatment. By collecting samples, researchers hope to find markers that could guide better, more personalized care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 1 and 18 years old.
- They must have a recent diagnosis of nephrotic syndrome (kidney condition causing protein in the urine and swelling).
- They must have significant protein in the urine, low albumin (a blood protein), and swelling (edema).
- They cannot have received any prior steroid treatment (like prednisone) for this condition.
- Their kidney problem must not be caused by another condition, like autoimmune disease or vasculitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks children with nephrotic syndrome whose kidney disease does not respond to usual treatments. It aims to collect information and samples to better understand resistant forms of the condition.
This study tests an injection (SG301) that targets a protein called CD38 to help children whose nephrotic syndrome keeps coming back or depends on steroids. The goal is to see if the treatment can reduce relapses and the need for steroids.
This trial tests if a hormone called ACTH can help children with nephrotic syndrome who have frequent relapses or need steroids to stay in remission. It aims to find a treatment that may reduce the need for steroids and prevent relapses.
This study uses interviews to understand how swelling from nephrotic syndrome affects daily life for children and their caregivers. It may help researchers design better care by capturing the patient and parent perspective.
This trial tests if dupilumab can help children with nephrotic syndrome who still have relapses despite standard treatments. It aims to find a better way to control the disease and reduce steroid side effects.
This is a long-term study that watches children and young adults with chronic kidney disease to understand how the illness changes and to improve care. You may be asked to complete regular visits and questionnaires, and your kidney function will be tracked over time.
Hear when a new Nephrotic Syndrome in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.